Estimation of Plasma BNP Levels in Rheumatic Heart Disease Patients at a Tertiary Care Teaching Hospital in Eastern India
DOI:
https://doi.org/10.48165/pvk2fd34Keywords:
Rheumatic heart disease, Aortic stenosis, Systolic pulmonary artery, BNPAbstract
Background: Brain natriuretic peptide (BNP) is a cardiac hormone secreted from the ventricular myocardium as a response to ventricular volume expansion and pressure overload. Rheumatic heart disease is a major health problem, mostly in developing country like India and particularly in this part of the country. In young age group rheumatic heart disease is the most common cause of cardiac morbidity and mortality. In this study our aim is to measure BNP levels in patients with RHD and to find out whether BNP concentrations correlate with clinical and echocardiographic findings. A total of 88 patients with rheumatic valve disease having different type of single or multivalvular lesions were included in this study. BNP was measured using the chemiluminescence methods (Bayer Centure, Germany) by BNP kit. 2D Echocardiography with colour Doppler was performed in all patients to assess the severity of the valve disease and for the measurement of pulmonary artery pressure. The plasma concentrations of BNP were found significantly higher in patients with aortic stenosis than in control (355.92±204.31pg/ml vs.183.39±93.51pg/ml, p < 0.001). The plasma BNP level was significantly higher in NYHA class IV than in class I (921.50±301.93 in class I and 125.85±52.88 pg/ml, p < 0.001 in class III). The independent determinants of higher BNP levels were NYHA functional class and systolic pulmonary artery pressure in multivariate analysis. Along with these results we got all other relative output which suggested that increased plasma BNP levels in patients with rheumatic heart disease compared with healthy subjects.
References
1. Sudoch T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature 1988;332:78.
2. Mukoyama M, Nakao K, Morii N, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuteric peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402.
3. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, andhormaonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581.
4. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195.
5. Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22.
6. Smith MD. Evaluation of valvular regurgitation by Doppler echocardiography Cardiol Clin 1991;9:193.
7. Perez JE, Ludbrook PA, Ahumada GG. Usefullness of Doppler echocardiography in detecting tricuspid valve stenosis. Am J Cardiol 1985;55:601.
8. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptide as cardiac hormones in normotensive and spontaneously hypertensive rats: the ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491.
9. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31:202.
